DCGI nod for Sanofi-GSK’s phase 3 trial of Covid vax in India
The trial aims to prevent symptomatic Covid-19 infections, as well as reduce severe disease and asymptomatic infection.
The trial aims to prevent symptomatic Covid-19 infections, as well as reduce severe disease and asymptomatic infection.
